JNJ

192.03

-0.36%↓

ABT

128.05

+0.39%↑

MDT

93.8

-2.87%↓

VEEV

289.29

-0.13%↓

A

145.94

+0.56%↑

JNJ

192.03

-0.36%↓

ABT

128.05

+0.39%↑

MDT

93.8

-2.87%↓

VEEV

289.29

-0.13%↓

A

145.94

+0.56%↑

JNJ

192.03

-0.36%↓

ABT

128.05

+0.39%↑

MDT

93.8

-2.87%↓

VEEV

289.29

-0.13%↓

A

145.94

+0.56%↑

JNJ

192.03

-0.36%↓

ABT

128.05

+0.39%↑

MDT

93.8

-2.87%↓

VEEV

289.29

-0.13%↓

A

145.94

+0.56%↑

JNJ

192.03

-0.36%↓

ABT

128.05

+0.39%↑

MDT

93.8

-2.87%↓

VEEV

289.29

-0.13%↓

A

145.94

+0.56%↑

Search

Incyte Corp

Abrir

SetorSaúde

88.75 1.78

Visão Geral

Variação de preço das ações

24h

Atual

Mín

87.23

Máximo

88.66

Indicadores-chave

By Trading Economics

Rendimento

247M

405M

Vendas

163M

1.2B

P/E

Médio do Setor

20.714

37.461

Margem de lucro

33.319

Funcionários

2,617

EBITDA

324M

582M

Recomendações

By TipRanks

Recomendações

Comprar

Previsão para 12 meses

+0.26% upside

Dividendos

By Dow Jones

Próximos Ganhos

28 de out. de 2025

Estatísticas de Mercado

By TradingEconomics

Capitalização de Mercado

3.5B

17B

Abertura anterior

86.97

Fecho anterior

88.75

Sentimento de Notícias

By Acuity

17%

83%

24 / 371 Ranking em Healthcare

Pontuação Técnica

By Trading Central

Confiança

Bullish Evidence

Incyte Corp Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

22 de out. de 2025, 22:47 UTC

Aquisições, Fusões, Aquisições de Empresas

Woodside Energy Signs Up Williams as Investor in Louisiana LNG Project -- Update

22 de out. de 2025, 22:13 UTC

Aquisições, Fusões, Aquisições de Empresas

Woodside Energy Signs Up Williams as Investor in Louisiana LNG Project

22 de out. de 2025, 21:20 UTC

Ganhos

Correction to IBM 3Q Sales Jump Article

22 de out. de 2025, 20:57 UTC

Ganhos

SAP Posts Higher 3Q Revenue, Operating Profit

22 de out. de 2025, 23:46 UTC

Conversa de Mercado

Global Forex and Fixed Income Roundup: Market Talk

22 de out. de 2025, 23:46 UTC

Conversa de Mercado

Nikkei May Decline Amid U.S.-China Trade Tensions -- Market Talk

22 de out. de 2025, 23:41 UTC

Conversa de Mercado

Gold Extends Pullback on Likely Profit-Taking -- Market Talk

22 de out. de 2025, 23:38 UTC

Conversa de Mercado

Gold Extends Pullback on Likely Profit-Taking -- Market Talk

22 de out. de 2025, 23:15 UTC

Ganhos

Tesla Profit Plunges Despite Third-Quarter Rush to Buy EVs -- 4th Update

22 de out. de 2025, 22:28 UTC

Conversa de Mercado

Alcoa Cautions About Spending More on U.S. Smelters -- Market Talk

22 de out. de 2025, 22:02 UTC

Ganhos

Tesla Profit Plunges Despite Third-Quarter Rush to Buy EVs -- 3rd Update

22 de out. de 2025, 21:59 UTC

Aquisições, Fusões, Aquisições de Empresas

Williams Cos.: Entered Into 1.5 Mtpa LNG Offtake Obligation >WMB

22 de out. de 2025, 21:58 UTC

Aquisições, Fusões, Aquisições de Empresas

Williams Cos. to Buy 10% Interest in Louisiana LNG LLC >WMB

22 de out. de 2025, 21:57 UTC

Aquisições, Fusões, Aquisições de Empresas

Williams Cos. to Buy 80% Ownership In, Become Operator of Driftwood Pipeline >WMB

22 de out. de 2025, 21:56 UTC

Aquisições, Fusões, Aquisições de Empresas

Williams Cos.: Strategic Partnership Entered With Woodside Energy to Invest in Louisiana LNG Project >WMB

22 de out. de 2025, 21:47 UTC

Aquisições, Fusões, Aquisições de Empresas

Woodside: Williams to Assume LNG Offtake Obligations for 10% of Produced Volumes

22 de out. de 2025, 21:47 UTC

Ganhos

SAP Stock Drops After Earnings. Cloud Revenue Fell Short. -- Barrons.com

22 de out. de 2025, 21:47 UTC

Aquisições, Fusões, Aquisições de Empresas

Woodside: Williams to Contribute Its Share of Capex for LNG Facility, Pipeline

22 de out. de 2025, 21:46 UTC

Aquisições, Fusões, Aquisições de Empresas

Woodside Energy Says Williams Deals Worth US$378 Million Including Capital Reimbursement

22 de out. de 2025, 21:45 UTC

Aquisições, Fusões, Aquisições de Empresas

Woodside Energy to Sell 80% Interest in Driftwood Pipeline Co. to Williams

22 de out. de 2025, 21:45 UTC

Aquisições, Fusões, Aquisições de Empresas

Woodside Energy to Sell 10% Interest in Louisiana LNG Holding Co. to Williams

22 de out. de 2025, 21:28 UTC

Conversa de Mercado
Ganhos

Correction to Alcoa Tariff Market Talk

22 de out. de 2025, 21:25 UTC

Ganhos

Wall Street Wonders if Grail's Cancer Test Results Are a True Positive -- Barrons.com

22 de out. de 2025, 21:17 UTC

Ganhos

Tesla Profit Plunges Despite Third-Quarter Rush to Buy EVs -- 2nd Update

22 de out. de 2025, 21:09 UTC

Conversa de Mercado
Ganhos

Alcoa Says Delivery Fee Covering Tariff Costs -- Market Talk

22 de out. de 2025, 21:00 UTC

Conversa de Mercado

ESG Roundup: Market Talk

22 de out. de 2025, 20:59 UTC

Ganhos

SAP Stock Drops After Earnings. Cloud Revenue Fell Short. -- Barrons.com

22 de out. de 2025, 20:51 UTC

Ganhos

SAP Reports Mixed Earnings. The Stock is Down. -- Barrons.com

22 de out. de 2025, 20:50 UTC

Conversa de Mercado

Basic Materials Roundup: Market Talk

22 de out. de 2025, 20:44 UTC

Ganhos

Kaiser Aluminum: For the Full Yr 2025, Now Expects Conversion Rev to Be Flat to Up 5% Yr-Over-Yr and Raises Adjusted EBITDA Outlook to Improve 20% to 25% Yr-Over-Yr >KALU

Comparação entre Pares

Variação de preço

Incyte Corp Previsão

Preço-alvo

By TipRanks

0.26% parte superior

Previsão para 12 meses

Média 87.53 USD  0.26%

Máximo 115 USD

Mínimo 60 USD

Com base em 19 analistas de Wall Street que oferecem metas de preço de 12 meses para Incyte Corp - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Comprar

19 ratings

8

Comprar

10

Manter

1

Vender

Pontuação Técnica

By Trading Central

59.52 / 62.66Suporte e Resistência

Curto Prazo

Bullish Evidence

Médio Prazo

Bearish Evidence

Longo Prazo

Bearish Evidence

Sentimento

By Acuity

24 / 371 Ranking em Saúde

Sentimento de Notícias

Evidência Muito Forte de Tendência de Alta

Volatilidade

Abaixo da média

Volume de Notícias (RCV)

Abaixo da média

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

$

Sobre Incyte Corp

Incyte Corporation, a biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutics for hematology/oncology, and inflammation and autoimmunity areas in the United States and internationally. The company offers JAKAFI (ruxolitinib) for treatment of intermediate or high-risk myelofibrosis, polycythemia vera, and steroid-refractory acute graft-versus-host disease; MONJUVI (tafasitamab-cxix)/MINJUVI (tafasitamab) for relapsed or refractory diffuse large B-cell lymphoma; PEMAZYRE (pemigatinib), a fibroblast growth factor receptor kinase inhibitor that act as oncogenic drivers in liquid and solid tumor types; ICLUSIG (ponatinib) to treat chronic myeloid leukemia and Philadelphia-chromosome positive acute lymphoblastic leukemia; and ZYNYZ (retifanlimab-dlwr) to treat adults with metastatic or recurrent locally advanced Merkel cell carcinoma, as well as OPZELURA cream for treatment of atopic dermatitis. Its clinical stage products include retifanlimab under Phase 3 clinical trials for squamous cell carcinoma of the anal canal and non-small cell lung cancer; axatilimab, an anti-CSF-1R monoclonal antibody under Phase 2 that is being developed as a therapy for patients with chronic GVHD; INCA033989 to inhibit oncogenesis; INCB160058, which is being developed as a disease-modifying therapeutic; and INCB99280 and INCB99318 for the treatment solid tumors. The company also develops INCB123667, INCA32459, and INCA33890, as well as Ruxolitinib cream, Povorcitinib, and INCA034460. It has collaboration out-license agreements with Novartis and Lilly; in-license agreements with Agenus, Merus, MacroGenics, and Syndax; and collaboration and license agreement with China Medical System Holdings Limited for the development and commercialization of povorcitinib. The company sells its products to specialty, retail, and hospital pharmacies, distributors, and wholesalers. The company was formerly known as Incyte Genomics Inc and changed its name to Incyte Corporation in March 2003. Incyte Corporation
help-icon Live chat